Our primary outcome will be overall survival at 1 year with secondary outcomes being disease-free survival at 1, 3, and 5 years. We will also be looking at overall survival at these time points.
Not Available
What is the full name of this clinical trial?
Retrospective Review: Signet Ring Cell Histologic Subtype in Gastric Adenocarcinoma: Survival and Prognosis